Gate Neurosciences Overview
- Year Founded
-
2018

- Status
-
Private
- Employees
-
13

- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$25M
- Investors
-
7
Gate Neurosciences General Information
Description
Developer of neuronal therapeutics designed to treat central neurologic and psychiatric disorders. The company's therapies are designed to function by enhancing neuroplasticity, strengthening neuronal connections, and rebalancing signaling to restore healthy brain function that addresses underlying disease pathophysiology, enabling patients and doctors to have a proper way to treat central nervous system conditions by creating safe, potent, and rapid-acting therapies.
Contact Information
Website
www.gateneuro.comCorporate Office
- 1210 Waterway Boulevard
- Indianapolis, IN 46202
- United States
Corporate Office
- 1210 Waterway Boulevard
- Indianapolis, IN 46202
- United States
Gate Neurosciences Timeline
Gate Neurosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Early Stage VC | 05-Oct-2022 | $25M | Completed | Pre-Clinical Trials | ||
4. Early Stage VC | 09-Dec-2021 | Completed | Pre-Clinical Trials | |||
3. Seed Round | 29-Mar-2021 | Completed | Pre-Clinical Trials | |||
2. Seed Round | 11-Jun-2019 | $4.5M | $4.5M | Completed | Pre-Clinical Trials | |
1. University Spin-Out | 01-Jan-2018 | Completed |
Gate Neurosciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Gate Neurosciences Signals
Gate Neurosciences Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
AbbVie Ventures | Corporate Venture Capital | Minority | ||
Innoviva | Corporation | Minority | ||
Luson BioVentures | Venture Capital | Minority | ||
Thornapple River Capital | Venture Capital | Minority | ||
Evolution VC Partners | Venture Capital | Minority |
Gate Neurosciences FAQs
-
When was Gate Neurosciences founded?
Gate Neurosciences was founded in 2018.
-
Where is Gate Neurosciences headquartered?
Gate Neurosciences is headquartered in Indianapolis, IN.
-
What is the size of Gate Neurosciences?
Gate Neurosciences has 13 total employees.
-
What industry is Gate Neurosciences in?
Gate Neurosciences’s primary industry is Other Healthcare Services.
-
Is Gate Neurosciences a private or public company?
Gate Neurosciences is a Private company.
-
What is Gate Neurosciences’s current revenue?
The current revenue for Gate Neurosciences is
. -
How much funding has Gate Neurosciences raised over time?
Gate Neurosciences has raised $45.6M.
-
Who are Gate Neurosciences’s investors?
AbbVie Ventures, Innoviva, Luson BioVentures, Thornapple River Capital, and Evolution VC Partners are 5 of 7 investors who have invested in Gate Neurosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »